向的细胞内铜储库增强肝癌免疫疗法
Tianao Xie1,2,3, Yukai Shan1,2,3, Win Topatana1,2,3
1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|July 21, 2025
概括
肝细胞癌是一种"冷瘤",可以通过重新编程其免疫微环境来治疗. 声波可激活纳米粒子触发cuproptosis和免疫细胞死亡,增强免疫治疗的有效性.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 是一种具有低免疫原性的"冷瘤",导致对常规免疫疗法的反应不佳.
- 调节瘤免疫微环境 (TIME) 对于提高癌症治疗疗效至关重要.
研究的目的:
- 开发可激活纳米颗粒 (STCN),诱导内源性cuproptosis,用于增强HCC的免疫疗法.
- 研究STCN在重编程TIME和增强抗癌免疫反应方面的潜力.
主要方法:
- 制造N,N,N',N'-tetrakis ((2-pyridinylmethyl) -1,2-ethanediamine (TPEN) 封装的针对癌症的纳米粒子 (STCN).
- 超声波照射触发TPEN释放,铜化,以及随后的反应性氧物种 (ROS) 生成.
- 在HCC模型中对cuproptosis诱导,免疫细胞死亡 (ICD) 和T淋巴细胞透的评估.
- 在体内对抗编程细胞死亡蛋白1 (PD1) 进行组合疗法的评估.
主要成果:
- 通过叶酸介导的内细胞化,STCN被HCC细胞有效地内化.
- 超声波触发的TPEN释放启动了导致cuproptosis,ROS生产和ICD的级联.
- 与抗PD1治疗相结合的STCNs在体内和其他固体瘤模型中显示出显著的抗瘤疗效.
结论:
- 通过STCNs内源性cuproptosis免疫促进是一种可行的策略,以克服"冷瘤"的挑战.
- 这种方法有效地重新编程瘤免疫微环境,提高免疫疗法结果.
- 开发的策略对各种固体瘤具有广泛的治疗潜力,为癌症治疗提供了一个有希望的新途径.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664


